[1] |
THAPA K, SINGH TG, KAUR A. Cyclic nucleotide phosphodiesterase inhibition as a potential therapeutic target in renal ischemia reperfusion injury[J]. Life Sci, 2021, 282: 119843. DOI: 10.1016/j.lfs.2021.119843.
|
[2] |
G BARDALLO R, PANISELLO-ROSELLÓ A, SANCHEZ-NUNO S, et al. Nrf2 and oxidative stress in liver ischemia/reperfusion injury[J]. FEBS J, 2022, 289(18): 5463-5479. DOI: 10.1111/febs.16336.
|
[3] |
WU MY, YIANG GT, LIAO WT, et al. Current mechanistic concepts in ischemia and reperfusion injury[J]. Cell Physiol Biochem, 2018, 46(4): 1650-1667. DOI: 10.1159/000489241.
|
[4] |
MARTIN JL, GRUSZCZYK AV, BEACH TE, et al. Mitochondrial mechanisms and therapeutics in ischaemia reperfusion injury[J]. Pediatr Nephrol, 2019, 34(7): 1167-1174. DOI: 10.1007/s00467-018-3984-5.
|
[5] |
JUN W, BENJANUWATTRA J, CHATTIPAKORN SC, et al. Necroptosis in renal ischemia/reperfusion injury: a major mode of cell death?[J]. Arch Biochem Biophys, 2020, 689: 108433. DOI: 10.1016/j.abb.2020.108433.
|
[6] |
FENG Y, IMAM ALIAGAN A, TOMBO N, et al. RIP3 translocation into mitochondria promotes mitofilin degradation to increase inflammation and kidney injury after renal ischemia-reperfusion[J]. Cells, 2022, 11(12): 1894. DOI: 10.3390/cells11121894.
|
[7] |
SHEN B, HE Y, ZHOU S, et al. TRPC6 may protect renal ischemia-reperfusion injury through inhibiting necroptosis of renal tubular epithelial cells[J]. Med Sci Monit, 2016, 22: 633-641. DOI: 10.12659/msm.897353.
|
[8] |
HUANG J, CAO H, CUI B, et al. Mesenchymal stem cells-derived exosomes ameliorate ischemia/reperfusion induced acute kidney injury in a porcine model[J]. Front Cell Dev Biol, 2022, 10: 899869. DOI: 10.3389/fcell.2022.899869.
|
[9] |
DING C, ZHENG J, WANG B, et al. Exosomal microRNA-374b-5p from tubular epithelial cells promoted M1 macrophages activation and worsened renal ischemia/reperfusion injury[J]. Front Cell Dev Biol, 2020, 8: 587693. DOI: 10.3389/fcell.2020.587693.
|
[10] |
ZHANG Y, WANG J, YANG B, et al. Transfer of microRNA-216a-5p from exosomes secreted by human urine-derived stem cells reduces renal ischemia/reperfusion injury[J]. Front Cell Dev Biol, 2020, 8: 610587. DOI: 10.3389/fcell.2020.610587.
|
[11] |
SHEN B, MEI M, PU Y, et al. Necrostatin-1 attenuates renal ischemia and reperfusion injury via meditation of HIF-1α/miR-26a/TRPC6/PARP1 signaling[J]. Mol Ther Nucleic Acids, 2019, 17: 701-713. DOI: 10.1016/j.omtn.2019.06.025.
|
[12] |
ZHANG Y, CHANG Y, HAN Z, et al. Estrogen protects against renal ischemia-reperfusion injury by regulating Th17/Treg cell immune balance[J]. Dis Markers, 2022: 7812099. DOI: 10.1155/2022/7812099.
|
[13] |
ZHOU Z, YOU B, JI C, et al. Implications of crosstalk between exosome-mediated ferroptosis and diseases for pathogenesis and treatment[J]. Cells, 2023, 12(2): 311. DOI: 10.3390/cells12020311.
|
[14] |
LIN Z, WU Y, XU Y, et al. Mesenchymal stem cell-derived exosomes in cancer therapy resistance: recent advances and therapeutic potential[J]. Mol Cancer, 2022, 21(1): 179. DOI: 10.1186/s12943-022-01650-5.
|
[15] |
LAI JJ, CHAU ZL, CHEN SY, et al. Exosome processing and characterization approaches for research and technology development[J]. Adv Sci (Weinh), 2022, 9(15): e2103222. DOI: 10.1002/advs.202103222.
|
[16] |
KEERTHIKUMAR S, CHISANGA D, ARIYARATNE D, et al. ExoCarta: a web-based compendium of exosomal cargo[J]. J Mol Biol, 2016, 428(4): 688-692. DOI: 10.1016/j.jmb.2015.09.019.
|
[17] |
HU Q, SU H, LI J, et al. Clinical applications of exosome membrane proteins[J]. Precis Clin Med, 2020, 3(1): 54-66. DOI: 10.1093/pcmedi/pbaa007.
|
[18] |
SOHRABI B, DAYERI B, ZAHEDI E, et al. Mesenchymal stem cell (MSC)-derived exosomes as novel vehicles for delivery of miRNAs in cancer therapy[J]. Cancer Gene Ther, 2022, 29(8/9): 1105-1116. DOI: 10.1038/s41417-022-00427-8.
|
[19] |
CHEN S, SUN F, QIAN H, et al. Preconditioning and engineering strategies for improving the efficacy of mesenchymal stem cell-derived exosomes in cell-free therapy[J]. Stem Cells Int, 2022: 1779346. DOI: 10.1155/2022/1779346.
|
[20] |
KIMIZ-GEBOLOGLU I, ONCEL SS. Exosomes: large-scale production, isolation, drug loading efficiency, and biodistribution and uptake[J]. J Control Release, 2022, 347: 533-543. DOI: 10.1016/j.jconrel.2022.05.027.
|
[21] |
FERREIRA D, MOREIRA JN, RODRIGUES LR. New advances in exosome-based targeted drug delivery systems[J]. Crit Rev Oncol Hematol, 2022, 172: 103628. DOI: 10.1016/j.critrevonc.2022.103628.
|
[22] |
王光华, 王桂斌, 滕晓华. 间充质干细胞来源外泌体治疗缺血再灌注损伤分子机制及研究进展[J]. 生物医学工程与临床, 2021, 25(5): 639-643. DOI: 10.13339/j.cnki.sglc.20210820.019.WANG GH, WANG GB, TENG XH. Review of exosomes derived from mesenchymal stem cells in protecting ischemia-reperfusion injury[J]. Biomed Eng Clin Med, 2021, 25(5): 639-643. DOI: 10.13339/j.cnki.sglc.20210820.019.
|
[23] |
LIAO YJ, MA YX, HUANG LL, et al. Augmenter of liver regeneration protects the kidney against ischemia-reperfusion injury by inhibiting necroptosis[J]. Bioengineered, 2022, 13(3): 5152-5167. DOI: 10.1080/21655979.2022.2037248.
|
[24] |
刘昕蓓, 刘文静. 调控性细胞死亡在肾脏缺血再灌注损伤中的研究进展[J]. 生理学报, 2022, 74(2): 320-332. DOI: 10.13294/j.aps.2022.0025.LIU XB, LIU WJ. The role of regulated cell death in renal ischemia-reperfusion injury[J]. Acta Physiol Sin, 2022, 74(2): 320-332. DOI: 10.13294/j.aps.2022.0025.
|
[25] |
DEGTEREV A, HUANG Z, BOYCE M, et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury[J]. Nat Chem Biol, 2005, 1(2): 112-119. DOI: 10.1038/nchembio711.
|
[26] |
DELLA TORRE L, NEBBIOSO A, STUNNENBERG HG, et al. The role of necroptosis: biological relevance and its involvement in cancer[J]. Cancers (Basel), 2021, 13(4): 684. DOI: 10.3390/cancers13040684.
|
[27] |
ASHOUR H, HASHEM HA, KHOWAILED AA, et al. Necrostatin-1 mitigates renal ischaemia-reperfusion injury - time dependent - via aborting the interacting protein kinase (RIPK-1)-induced inflammatory immune response[J]. Clin Exp Pharmacol Physiol, 2022, 49(4): 501-514. DOI: 10.1111/1440-1681.13625.
|
[28] |
LIU Z, LI C, LI Y, et al. Propofol reduces renal ischemia reperfusion-mediated necroptosis by up-regulation of SIRT1 in rats[J]. Inflammation, 2022, 45(5): 2038-2051. DOI: 10.1007/s10753-022-01673-6.
|
[29] |
YUAN X, LI D, CHEN X, et al. Extracellular vesicles from human-induced pluripotent stem cell-derived mesenchymal stromal cells (hiPSC-MSCs) protect against renal ischemia/reperfusion injury via delivering specificity protein (SP1) and transcriptional activating of sphingosine kinase 1 and inhibiting necroptosis[J]. Cell Death Dis, 2017, 8(12): 3200. DOI: 10.1038/s41419-017-0041-4.
|
[30] |
WANG H, CHENG X, TIAN J, et al. TRPC channels: structure, function, regulation and recent advances in small molecular probes[J]. Pharmacol Ther, 2020, 209: 107497. DOI: 10.1016/j.pharmthera.2020.107497.
|
[31] |
ENGLISCH CN, PAULSEN F, TSCHERNIG T. TRPC channels in the physiology and pathophysiology of the renal tubular system: what do we know?[J]. Int J Mol Sci, 2022, 24(1): 181. DOI: 10.3390/ijms24010181.
|
[32] |
DRYER SE, KIM EY. The effects of TRPC6 knockout in animal models of kidney disease[J]. Biomolecules, 2022, 12(11): 1710. DOI: 10.3390/biom12111710.
|
[33] |
郭文文, 袁圆, 魏华锋, 等. 瞬时受体电位阳离子通道蛋白6在缺血-再灌注损伤中的作用研究进展[J]. 器官移植, 2022, 13(5): 659-665. DOI: 10.3969/j.issn.1674-7445.2022.05.017.GUO WW, YUAN Y, WEI HF, et al. Research progress on the role of transient receptor potential canonical 6 in ischemia-reperfusion injury[J]. Organ Transplant, 2022, 13(5): 659-665. DOI: 10.3969/j.issn.1674-7445.2022.05.017.
|
[34] |
ZHENG Z, TSVETKOV D, BARTOLOMAEUS TUP, et al. Role of TRPC6 in kidney damage after acute ischemic kidney injury[J]. Sci Rep, 2022, 12(1): 3038. DOI: 10.1038/s41598-022-06703-9.
|
[35] |
SHEN B, MEI M, AI S, et al. TRPC6 inhibits renal tubular epithelial cell pyroptosis through regulating zinc influx and alleviates renal ischemia-reperfusion injury[J]. FASEB J, 2022, 36(10): e22527. DOI: 10.1096/fj.202200109RR.
|
[36] |
PU Y, ZHAO H, SHEN B, et al. TRPC6 ameliorates renal ischemic reperfusion injury by inducing Zn2+ influx and activating autophagy to resist necrosis[J]. Ann Transl Med, 2022, 10(5): 249. DOI: 10.21037/atm-21-5837.
|